Do extenders help with erectile dysfunction? This question reflects growing interest in non-pharmacological approaches to ED, but the evidence remains limited. Penis extenders, or penile traction devices, apply continuous stretching force to penile tissue over months of daily use. Whilst originally developed for Peyronie's disease, they are increasingly marketed for erectile dysfunction. However, these devices do not address the underlying vascular, neurological, or psychological causes of ED. This article examines the evidence for penis extenders in ED treatment, compares them to established therapies, and outlines important safety considerations for men seeking effective, evidence-based solutions.

What Are Penis Extenders and How Do They Work?

Penis extenders, also known as penile traction devices, are mechanical devices designed to apply gentle, continuous stretching force to the penis over extended periods. These devices typically consist of a plastic ring that sits at the base of the penis, two dynamic rods running along the shaft, and a support system at the glans. Users gradually increase the tension over weeks or months, with manufacturers commonly recommending daily use for several hours.

The proposed mechanism of action is based on the principle of tissue expansion through mechanical traction. Sustained stretching is thought to stimulate mechanotransduction—a process whereby mechanical forces trigger cellular responses including cell proliferation and collagen remodelling. This is similar in principle to mechanisms used in orthopaedic limb lengthening. When applied to penile tissue, this continuous tension may encourage remodelling of the tunica albuginea (the fibrous covering of the erectile chambers). However, evidence that traction increases the functional capacity of the corpora cavernosa—the erectile tissue chambers that fill with blood during an erection—is limited and largely confined to modest changes in stretched penile length reported in some studies.

Penis extenders were originally developed for men with Peyronie's disease, a condition characterised by penile curvature due to fibrous plaque formation. The devices have subsequently been marketed for penile lengthening and, more recently, as a potential treatment for erectile dysfunction. It is important to distinguish between these devices and vacuum erection devices (VEDs), which work through negative pressure rather than traction and are listed as an option in NICE Clinical Knowledge Summaries (CKS) for erectile dysfunction management.

In the UK, devices marketed with medical claims (such as treating Peyronie's disease or erectile dysfunction) are classified as medical devices and should carry UKCA or CE marking and be registered with the Medicines and Healthcare products Regulatory Agency (MHRA). Many extender devices are available without prescription. Users are typically advised in study protocols and manufacturer guidance to wear the device for 4–6 hours daily over a period of 3–6 months to achieve purported benefits, though adherence to such demanding regimens is often poor.

Do Extenders Help with Erectile Dysfunction?

The relationship between penis extenders and erectile dysfunction treatment remains unclear, with limited high-quality evidence to support their use specifically for ED. Erectile dysfunction is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It has multiple potential causes including vascular disease, neurological conditions, hormonal imbalances, psychological factors, and medication side effects.

Penis extenders do not address the fundamental physiological mechanisms underlying most cases of erectile dysfunction. ED typically results from inadequate blood flow to the penis, impaired nerve signalling, or psychological factors—none of which are directly targeted by mechanical traction. Unlike established ED treatments such as phosphodiesterase-5 (PDE5) inhibitors, which enhance the nitric oxide pathway to improve penile blood flow, extenders do not have a clear pharmacological or physiological mechanism for improving erectile function.

Some manufacturers claim that extenders may help with ED by increasing penile tissue capacity or improving confidence through size enhancement. However, there is no robust evidence that increasing penile length improves erectile function. The psychological component of ED is well recognised, and theoretically, if a man experiences improved body image or reduced performance anxiety from using an extender, this might indirectly benefit erectile function. Nevertheless, this potential benefit remains speculative and unsupported by robust clinical evidence.

Men experiencing erectile dysfunction should consult their GP for proper assessment. ED can be an early indicator of cardiovascular disease or diabetes, and assessment should include cardiovascular risk evaluation (blood pressure, lipids, HbA1c or fasting glucose), medication review, and consideration of morning total testosterone if there are features of hypogonadism or low libido. Psychological factors should also be addressed. Evidence-based treatments including lifestyle modifications, PDE5 inhibitors, vacuum erection devices, intracavernosal injections, intraurethral alprostadil, and psychological therapy have established efficacy and should be considered according to NICE CKS guidance for erectile dysfunction.

Clinical Evidence for Penis Extenders in ED Treatment

The clinical evidence base for penis extenders specifically in treating erectile dysfunction is extremely limited and of generally poor quality. Most published studies have focused on penile length outcomes in men with Peyronie's disease or those seeking cosmetic enhancement, rather than erectile function as a primary outcome measure.

Systematic reviews examining penile traction therapy have found some evidence for modest increases in penile length (typically 1–3 cm when stretched) after several months of use, but these studies predominantly enrolled men without erectile dysfunction. Where erectile function has been assessed as a secondary outcome, results have been inconsistent and confounded by small sample sizes, lack of control groups, and high dropout rates (often 30–50%) due to the demanding nature of the treatment regimen.

One small study published in the British Journal of Urology International examined men with Peyronie's disease using traction devices and reported some improvement in erectile function scores, but these men had a specific anatomical cause for their ED (penile curvature limiting penetration) rather than the vascular or neurogenic causes that account for most ED cases. The applicability of these findings to the general ED population is therefore questionable and should not be extrapolated.

Importantly, no large-scale randomised controlled trials have compared penis extenders to placebo or established ED treatments with erectile function as the primary endpoint. Penis extenders marketed for medical purposes in the UK are medical devices and should carry UKCA or CE marking and be registered with the MHRA. However, they are not included in NICE CKS guidance for erectile dysfunction management, reflecting the lack of robust evidence for this indication.

The current evidence is insufficient to recommend penis extenders as a treatment for erectile dysfunction. Men seeking ED treatment should discuss evidence-based options with their healthcare provider rather than relying on devices with unproven efficacy for this indication.

Comparing Extenders to Other Erectile Dysfunction Treatments

When compared to established erectile dysfunction treatments, penis extenders lack the robust evidence base, regulatory approval for ED, and clinical endorsement that characterise first-line therapies. Understanding these differences is essential for informed decision-making.

Phosphodiesterase-5 (PDE5) inhibitors such as sildenafil, tadalafil, and vardenafil are the first-line pharmacological treatment for ED according to NICE CKS guidance. These medications work by enhancing the natural erectile response through inhibition of PDE5, an enzyme that breaks down cyclic GMP, thereby promoting smooth muscle relaxation and increased blood flow to the penis. Clinical trials have demonstrated efficacy rates typically in the range of 60–70% across diverse ED populations, though response varies by underlying cause. These medications have well-characterised safety profiles and are available on NHS prescription following appropriate assessment. Sildenafil is also available as a Pharmacy (P) medicine (Viagra Connect) for men meeting specific criteria. Important contraindications include concurrent use of nitrates and significant hypotension.

Vacuum erection devices (VEDs) are mechanical treatments that create negative pressure around the penis, drawing blood into the erectile tissue. Unlike penis extenders, VEDs are listed as an option in NICE CKS for erectile dysfunction management, have extensive clinical evidence supporting their use, and may be available on NHS prescription (subject to local commissioning and Drug Tariff listing). They are particularly suitable for men who cannot take PDE5 inhibitors or prefer non-pharmacological options.

Intracavernosal injections and intraurethral alprostadil represent second-line treatments with proven efficacy for men who do not respond to oral medications. These treatments directly deliver vasoactive substances to penile tissue, producing erections through local pharmacological action.

Psychological therapy and psychosexual counselling address the psychological components of ED and are recommended, particularly when psychological factors are identified or when ED affects relationships and quality of life.

Penis extenders differ fundamentally from these treatments in that they do not target the pathophysiological mechanisms of ED, lack robust evidence for this indication, require months of daily use (compared to on-demand treatments), and have no established efficacy for erectile function improvement. The time investment required—typically 4–6 hours daily for 3–6 months in study protocols—is substantial compared to taking a tablet 30–60 minutes before sexual activity.

Safety Considerations and Potential Risks of Penis Extenders

Whilst penis extenders are generally marketed as safe devices, their use is not without potential risks and complications. Men considering these devices should be aware of possible adverse effects and safety considerations.

Common adverse effects reported in clinical studies include:

• Pain or discomfort during use, particularly when tension is increased too rapidly

• Skin irritation, bruising, or abrasions where the device contacts penile tissue

• Temporary numbness or altered sensation due to compression of nerves

• Red spots or petechiae (small areas of bleeding under the skin)

• Difficulty maintaining the device in position, leading to frustration and discontinuation

More serious potential complications, though less commonly reported, include:

• Penile oedema (swelling) from prolonged compression

• Tissue damage from excessive tension or prolonged use

• Exacerbation of Peyronie's disease in susceptible individuals

• Psychological distress if expected results are not achieved

The high dropout rates observed in clinical studies (often 30–50%) suggest that many men find the devices uncomfortable, impractical, or incompatible with daily life. The requirement for several hours of daily use can interfere with work, physical activity, and normal clothing.

Safety recommendations for anyone considering penis extenders include:

• Consult a GP before use, particularly if you have erectile dysfunction, Peyronie's disease, or other penile conditions

• Follow manufacturer instructions carefully regarding tension increases and duration of use

• Do not use the device during sleep

• Start with low tension and increase gradually; inspect skin frequently for signs of irritation or injury

• Exercise caution if you have a bleeding disorder, are taking anticoagulant medication, or have reduced penile sensation (e.g., due to diabetes or neuropathy)

• Discontinue use immediately if you experience severe pain, numbness, discolouration, or any concerning symptoms

• Do not use extenders as a substitute for medical evaluation and treatment of erectile dysfunction

• Be aware that devices purchased online may not meet UK safety standards or provide accurate usage guidance

If you experience a suspected adverse effect or problem with a penis extender device, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

When to seek medical attention: Contact your GP promptly if you experience persistent pain, penile deformity, prolonged numbness, or skin breakdown. Seek urgent medical care if you notice severe or worsening pain, blue, black, or cold discolouration of the glans, or any signs of acute penile injury. If you have erectile dysfunction, seek proper medical assessment rather than self-treating with unproven devices, as ED may indicate underlying cardiovascular disease or diabetes requiring investigation and management.

Frequently Asked Questions